Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Who is buying the warrant conversions?

Re: palomar, my calculations suggest that 40+mil shares have

posted on Apr 04, 2007 10:30PM

Let’s say that L&S have made arrangements for indirect control of these 40 million shares that were picked up in the .50 to .80 cent range (not at all likely in IMHO). And let’s round up and assume that L&S have direct control of 35 million shares.

Based on the above assumptions, L&S would have direct/indirect control of 75 million shares.

As of 2/28/07, there were 378,668,118 shares outstanding.

Based on the above, L&S would have direct/indirect control of just under 20% of the outstanding shares.

It is tough to compete with a 20% block vote. That said, I have seen nothing that backs up a view that L&S have this much control…; I think that the number is smaller. But, If I’m wrong…Agora members, please express your view.

I think that the retail shareholder has much more control than we realize.


MHO…

Share
New Message
Please login to post a reply